PATENT CLAIM ANALYSIS

Application Number: 15869162
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "059000"]

Abstract:
Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.

Claim (Index 15):
A dry powder inhaler, which contains a pharmaceutical formulation according to  claim 12 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.23333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14607289', '10592701', '14820939', '13078057', '13195885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7487053778470795
- 35 USC 102 Novelty (BERT): 0.4957981624105834
- Combined Prediction Score: 0.7234146563034298
- Mean Citation Score: 232.15262
- Max Citation Score: 247.23987
- Similarity Product: 190.6557524705744

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test